Priority Date: 20.01.12 (US 201261588936P)

ANTI-CXCR3 ANTIBODIES

  • Application ID: EP13702548
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
1068.17
2 offices
active in Legal Services
no operation time available
1007.76
1 office
active in Legal Services

Specialization

This patent has the IPC class C07 (ORGANIC CHEMISTRY) Cabinet Lavoix and Lavoix Munich are specialized in C07. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 20.01.2012 - Priority Date (US 201261588936P)
  • 25.07.2013 - Publication A2 (WO2013109974)
  • 26.11.2014 - Publication A2 (EP2804878)

IPC Classification